Outcome of multi-drug resistant tuberculosis in Belgrade

D. Mandic, D. Popovac (Belgrade, Yugoslavia)

Source: Annual Congress 2001 - Problems in treatment of TB
Session: Problems in treatment of TB
Session type: Thematic Poster Session
Number: 2064
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Mandic, D. Popovac (Belgrade, Yugoslavia). Outcome of multi-drug resistant tuberculosis in Belgrade. Eur Respir J 2001; 16: Suppl. 31, 2064

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment outcome of multi-drug resistant tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004


Outcome of multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Outcomes of patients with multidrug resistant tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Primary multi-drug resistant tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India
Source: Eur Respir J 2002; 20: Suppl. 38, 615s
Year: 2002

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Collapsotherapy of multi-drug resistant TB in prisoners
Source: Eur Respir J 2003; 22: Suppl. 45, 522s
Year: 2003

Management of MDR tuberculosis
Source: Short video discussion 2021
Year: 2021

Multi-drug resistant pulmonary tuberculosis in Belarus
Source: Annual Congress 2007 - Epidemiology of various lung diseases
Year: 2007


Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003

Treating multiple-drug resistant tuberculosis
Source: International Congress 2018 – PG13 Challenges in the treatment of tuberculosis
Year: 2018


Circulation of multidrug resistant strains of Mycobacterium tuberculosis in Abkhasia
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006


Morphology of multi-drug resistant TB in the experiment
Source: Eur Respir J 2007; 30: Suppl. 51, 202s
Year: 2007

Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019


Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Short course of chemotherapy of multidrug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004

Outcome of pulmonary multidrug-resistant tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 419s
Year: 2007